Why Appen, GQG, Paradigm, and Talga shares are tumbling lower

These ASX shares are ending the week in the red…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a decline. In afternoon trade, the benchmark index is down 0.6% to 6,774.4 points.

Four ASX shares that are falling more than most today are listed below. Here's why they are dropping:

Disappointed man with his head on his hand looking at a falling share price his a laptop.

Image source: Getty Images

Appen Ltd (ASX: APX)

The Appen share price is down a further 2.5% to $2.87. Investors have continued to sell down this artificial intelligence data services company's shares in response to a very disappointing update on Thursday. That update reveals that Appen expects FY 2022 revenue in the range of US$375 million to US$395 million and constant currency EBITDA of US$13 million to US$18 million. The latter will be down 77.2% to 83.5% over the prior corresponding period. In other news, this morning Ord Minnett retained its sell rating and cut its price target to $2.60.

GQG Partners Inc (ASX: GQG)

The GQG share price is down 4% to $1.53. This has been driven by a disappointing funds under management (FUM) update from GQG this morning. The fund manager revealed that its FUM fell 9.3% during September to US$79.2 billion.

Paradigm Biopharmaceuticals Ltd (ASX: PAR)

The Paradigm Biopharmaceuticals share price is down 13% to $1.68. This is despite there being no news out of the drug development company today. However, with its shares rocketing materially higher this week, some traders could be taking profit off the table. After all, the Paradigm share price is still up 15% this week despite this decline. This strong gain was driven by the release of promising study results.

Talga Group Ltd (ASX: TLG)

The Talga share price is down 12% to $1.17. This has been driven by the battery materials company announcing firm commitments for a $22 million placement. The company is raising the funds at a price of $1.10 per share, which represents a 17% discount to the Talga share price prior to its trading halt. Proceeds will be used partly to fund Talga's advancement of the Vittangi Anode Project and the expanded operation of the Electric Vehicle Anode qualification plant.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Appen Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the week for investors this Friday.

Read more »

Woman thinking in a supermarket.
Dividend Investing

Coles stock vs Woolworths shares: Who had the better dividend this week?

Let's check the receipts on Coles and Woolies this week.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

4 ASX All Ords shares with 40% to 90% upside post-results: experts

These shares have major upside potential, according to the experts.

Read more »

Woman looking at a laptop and thinking.
Broker Notes

4 ASX shares scoring upgrades in the final week of earnings season

Brokers have increased their ratings on Sigma Healthcare, Adairs, Netwealth, and other shares.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Buy, hold, sell: Netwealth, Sigma Healthcare, and Wesfarmers shares

The team at Morgans has given its verdict on these shares.

Read more »

Smiling kid flexing his muscles.
Broker Notes

3 ASX 200 shares to buy post-results: broker

Morgans has reviewed these companies' FY26 reports and given them a buy rating.

Read more »

ASX board.
ASX Share Market News

Why the ASX 200 is pushing higher as rate hike fears grow

Tech stocks are leading the market rebound today.

Read more »

Small kid giving a thumbs up.
Broker Notes

9 ASX 200 shares with strengthened buy ratings this week

Brokers are positive on Paladin Energy, Coles, WiseTech, Centuria Capital, and other shares.

Read more »